Radioembolization of colorectal hepatic metastases using Yttrium-90 microspheres

Cancer

Volumn 115, Issue 9, 2009, Pages 1849-1858

  Mulcahy, Mary F ^b   Lewandowski, Robert J ^b   Ibrahim, Saad M ^b   Sato, Kent T ^b   Ryu, Robert K ^b   Atassi, Bassel ^b   Newman, Steven ^b   Talamonti, Mark ^c   Omary, Reed A ^b   Benson III, Al ^b   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

Fluorodeoxyglucose positron emission tomography; Hepatic arterial infusion chemotherapy; radioembolization; Radiofrequency ablation; Systemic agents; TheraSphere; Time to hepatic progression; Transarterial chemoembolization; Yttrium 90

Indexed keywords

BEVACIZUMAB; BILIRUBIN; CETUXIMAB; FLUOROURACIL; IRINOTECAN; MICROSPHERE; OXALIPLATIN; YTTRIUM 90;

ABDOMINAL PAIN; ADULT; AGED; ANATOMY; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM ULCER; DRUG TOXICITY; FATIGUE; FEMALE; FEVER; HUMAN; KAPLAN MEIER METHOD; LIVER; LIVER DISEASE; LIVER FUNCTION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NAUSEA; ONCOLOGY; OVERALL SURVIVAL; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIOEMBOLIZATION; SAFETY; THERAPY EFFECT; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; SURVIVAL ANALYSIS; YTTRIUM RADIOISOTOPES;

EID: 65649154488     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24224     Document Type: Article

References (38)

1. Jemal A. Murray T. Samuels A. Ghafoor A. Ward E. Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003:53:5-26.
2. Sassori A. R. Sigurdson ER. Surgical treatment of liver metastases. Semin Oncol. 2002;29:107-118. (Pubitemid 34297281)
3. Bengtsson G. Carlsson G. Hafstrom L. Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981;141:586-589.
4. Wagner J. S. Aclson M. A. Van Heerden J. A. Adson M. H. Ilstrup DM. The natural history of hepatic metastases from colorectal cancer, A comparison with resective treatment. Ann Surg. 1984; 199:502-508. (Pubitemid 14105105)
5. Tomlinson J. S. Jarnagin W. R. DeMatteo R. P. et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin Oncol 2007;25:4575-4580. (Pubitemid 350035315)
6. Bentrem D. J. Dematteo R. P. Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med. 2005;56: 139-156. (Pubitemid 40299777)
7. Adam R. Aloia T. Levi F. et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007;25:4593-4602. (Pubitemid 350035318)
8. Goldberg R. M. Rothenberg M. L. Van Cutsem E. et al. The continuum of care; a paradigm for the management of metastatic colorectal cancer. Oncologist. 2007;12:38-50. (Pubitemid 46143501)
9. Dancey J. E. Shepherd F. A. Paul K. et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y- microspheres. J Nucl Med. 2000;41: 1673-1681.
10. Russell J. L. Jr. Garden J. L. Flerron H. L. Dosimetry calculations for yttrium-90 used in the treatment of liver cancer. Endocurietherapy/Hyperthermia Oncol. 1988;4:171-186.
11. Snyder W. Ford M. Warner G. Watson S. 'S' Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs. New York, NY: Society of Nuclear Medicine; 1975.
12. Salem R. Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies; part 1: technical and methodologic considerations. J Vase Interv Radiol. 2006;17:1251-1278. (Pubitemid 44259009)
13. Ho S. Lau W. Y. Leung T. W. Chan M. Johnson P. J. Li AK. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med. 1997;24:293-298. (Pubitemid 27165858)
14. Lau W. Y. Ho S, Leung T. W. et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Rhys. 1998;40:583-592. (Pubitemid 28104228)
15. Kaplan E. L. Meier P. Nonparametric estimation from incomplete observations. J. Am Stat Assoc. 1958;53:457-481.
16. Chau I. Chan S. Cunningham D. Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives. Clin Colorectal Cancer. 2003;3:19-33. (Pubitemid 37220784)
17. Coutinho A. K. Rocha Lima CM. Metastatic colorectal cancer: systemic treatment in the new millennium. Cancer Control. 2003:10:224-238. (Pubitemid 36665845)
18. O'Neil B. H. Goldberg RM. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived. Expert Opin Investig Drugs. 2003;12:1939-1949. (Pubitemid 38008542)
19. Kennedy A. S. Coldwell D. Nutting C. et al. Resin 90Y- microsphere brachytherapy for unresectable colorectal liver metastases; modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412-425.
20. Lewandowshi R. J. Thurston K. G. Goin J. E. et al. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver; response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluoro-
21. deoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol. 2005; 16:1641-1651.
22. Sharma R. A. Van Hazel G. A. Morgan B. et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 2007;25:1099-1106. (Pubitemid 46596762)
23. Lewandowski R. J. Sato K. T. Atassi B. et al. Radioembolization with y microspheres: angiographic and technical considerations. Cardiovasc Interv Radiol. 2007;30:571-592. (Pubitemid 350092259)
24. Liu D. M. Salem R. Bui J. T. et al. Angiographic considerations in patients undergoing liver-directed dierapy. J Vasc Interv Radiol. 2005;16:911-935. (Pubitemid 40993515)
25. Salem R. Lewandowski R. J. Sato K. T. et al. Technical aspects of radioemboiization with 90Y microspheres. Tech Vasc Interv Radiol. 2007;10:12-29. (Pubitemid 350008084)
26. Salem R. Radioemboiization with 90Y microspheres: technical considerations. J Vasc Interv Radiol. 2007; 18:1460-1461. (Pubitemid 350001257)
27. Van Cutsem E. Peeters M. Siena S. et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007;25:1658-1664. (Pubitemid 46797944)
28. Cunningham D. Humbler Y. Siena S. et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer. N Engl J Med. 2004; 351:337-345. (Pubitemid 38944402)
29. Lenz H. J. Van Cutsem E. Khambata-Ford S. et al. Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines. J Clin Oncol. 2006;24; 4914-4921. (Pubitemid 46630920)
30. Gallagher D. J. Capanu M. Raggio G. Kemeny N. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol. 2007;18:1995-1999. (Pubitemid 350286238)
31. Wong C. Y. Qing F. Savin M. et al. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioemboiization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol. 2005; 16:1101-1106. (Pubitemid 41177123)
32. Wong C. Y. Salem R. Qing F. et al. Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med. 2004;45:1892-1897. (Pubitemid 47618448)
33. Wong C. Y. Salem R. Raman S. Gates V. L. Dworkin HJ. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging. 2002;29:815-820. (Pubitemid 34591700)
34. Koopman M. Antonini N. F. Douma J. et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet. 2007;370:135-142. (Pubitemid 47042893)
35. Seymour M. T. Maughan T. S. Ledermann J. A. et al. Different strategies of sequential and combination chemodierapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet. 2007;370:143-152. (Pubitemid 47042894)
36. Adam R. Avisar E. Ariche A. et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8:347-353. (Pubitemid 32422861)
37. Adson M. A. van Heerden J. A. Adson M. H. Wagner J. S. Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch Surg. 1984;119:647-651. (Pubitemid 14111054)
38. Siperstein A. E. Berber E. Ballem N. Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246:559-565; discussion 565-567. (Pubitemid 47480598)